Overview

The traditional role of the university has been to teach and conduct original research, but this situation is changing. As governments judge universities on new criteria - including the 'impact' they have - and as universities are driven to search for finance from new sources, those that run universities are increasingly looking to exploit the intellectual property created by their researchers to help deliver this impact and income. How this should be done, and whether it should be done at all, is subject to much debate. The key issues are: - What constitutes intellectual property? - Do academics or universities own IP? - Does the commercialisation of IP impact academic freedom? - How can IP best be exploited and who should be financially rewarded when it is? - What assistance can governments and other bodies provide? This book investigates these issues. After a review of how the current situation came to be, the views and experiences of a range of experts are presented, including those of a former high court judge, a senior lawyer, a patent attorney and professionals involved in technology transfer.The contributors examine whether the roles of higher education institutions have changed, what academics and universities should be doing, and how technology transfer can be made more effective and efficient. To conclude, a provocative look at the ethics of the situation is presented. This insightful and thought-provoking book will help readers to understand more about an increasingly important aspect of academia and business.

Full Product Details

9780857192325

Table of Contents

Reviews

Author Information

Professor Graham Richards has worked with spin-out companies since 1988, when he was involved in founding the University of Oxford's technology transfer company, Isis Innovation Ltd, which he went on to be a director of for 20 years. Professor Richards founded his own spin-out company, Oxford Molecular Ltd, in 1989 and was heavily involved with running this company for 11 years, until it was sold in 2000. He has also been a director of Catalyst Biomedica Ltd and a chairman of IP2IPO Group Plc, which later became the publicly quoted IP Group Plc. He is now a senior non-executive director of that company. Professor Richards has recently retired from Oxford University, where he was Head of the Chemistry Department.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available